Annexon, Inc.
Annexon, Inc.
ANNX
Valuace
70
Růst
33
Zdraví
75
Cena
$ 3.00
Dnes
--0.09 (-1.46%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-128%
ROA
-90%
PE
-4
PS
0
Cena 1R
1-7
⌀ Cena
2.94
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
02-03-2026
Poslední dividenda

Profil

Annexon, Inc., biofarmaceutická společnost v klinickém stadiu, objevuje a vyvíjí terapii autoimunitních, neurodegenerativních a očních poruch. C1q je iniciační molekula klasické cesty komplementu, která se zaměřuje na odlišné procesy onemocnění, jako je autoimunitní onemocnění zprostředkované protilátkami a neurodegenerace zprostředkovaná komplementem. Mezi její produktové kandidáty patří ANX005, monoklonální protilátka, která je v klinických studiích fáze II/III léčena pacienty s gillain-barrého syndromem; studie fáze II u pacientů s teplou autoimunitní hemolytickou anémií; a klinická studie fáze II pro Huntingtonovu chorobu a amyotrofickou laterální sklerózu. Společnost také vyvíjí ANX009, který je ve studii fáze Ib u pacientů s lupus nephritis; a ANX007, který je ve fázi II klinických studií k léčbě pacientů se zeměpisnou atrofií. Kromě toho se vyvíjí ANX105, vyšetřovaná monoklonální protilátka zaměřená na neurodegenerativní indikace, a ANX1502, vyšetřovaná perorální malá molekula pro léčbu určitých autoimunitních indikací. Společnost byla založena v roce 2011 a sídlí v Brisbane v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
106
Založení
2020-07-24
Adresa
1400 Sierra Point Parkway
CEO
Douglas E. Love

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues0.000.000.000.000.000.000.000.000.00
Cost of Revenues0.000.003,454.003,267.000.000.000.000.000.00
Gross Profit0.000.00-3,454.00-3,267.000.000.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.004,866.000.00
Cost of Revenues0.000.000.000.000.000.000.000.00834.00823.00
Gross Profit0.000.000.000.000.000.000.000.004,032.00-823.00
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.000.000.00113,756.00112,501.00100,066.0049,271.0024,524.0015,528.00
Selling General & Admin Expenses0.000.000.0029,967.0033,098.0030,647.0014,198.007,994.003,619.00
Depreciation & Amortization0.000.003,454.002,148.002,106.002,141.00667.00493.00488.00
Total Operating Expenses216,407.00216,407.00150,619.00143,723.00145,599.00130,713.0063,469.0032,518.0019,147.00
Operating Income-216,407.00-216,407.00-154,073.00-143,723.00-145,599.00-130,713.00-63,469.00-32,518.00-19,147.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0023,267.0027,893.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.005,908.006,888.00
Depreciation & Amortization-1,698.00546.00615.00537.00537.00538.00637.00538.00834.00823.00
Total Operating Expenses50,258.0057,018.0051,726.0057,405.0052,479.0039,442.0033,580.0028,572.0029,175.0034,781.00
Operating Income-50,258.00-57,018.00-51,726.00-57,405.00-52,479.00-39,442.00-33,580.00-28,572.00-30,009.00-34,781.00
Net Income TTM 20252024202320222021202020192018
Interest Income0.000.000.000.003,652.00390.000.000.000.00
Interest Expense0.000.000.000.003,652.000.000.000.000.00
Other Expense7,860.007,860.0015,873.009,486.003,652.00390.0057.00-4,661.00844.00
IBT-208,547.00-208,547.00-138,200.00-134,237.00-141,947.00-130,323.00-63,412.00-37,179.00-18,303.00
Income Tax Expense0.000.000.000.00-3,652.00-2,531.00-667.004.001.00
Net Income-208,547.00-208,547.00-138,200.00-134,237.00-138,295.00-127,792.00-62,745.00-37,183.00-18,304.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income-7,715.002,096.002,570.003,049.003,889.004,618.003,970.003,396.002,118.002,299.00
Interest Expense0.000.000.000.000.000.000.000.003,102.000.00
Other Expense145.002,096.002,570.003,049.003,889.004,618.003,970.003,396.002,118.002,299.00
IBT-50,113.00-54,922.00-49,156.00-54,356.00-48,590.00-34,824.00-29,610.00-25,176.00-27,891.00-32,482.00
Income Tax Expense0.000.000.000.000.000.000.000.003,640.00-538.00
Net Income-50,113.00-54,922.00-49,156.00-54,356.00-48,590.00-34,824.00-29,610.00-25,176.00-27,891.00-32,482.00
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-1.77$-2.53$-3.34$-3.70$-2.83$-1.60
EPS Diluted$0.00$0.00$0.00$-1.77$-2.53$-3.34$-3.70$-2.83$-1.60
Shares Outstanding155,105.83155,105.83137,404.1575,673.0854,673.5738,316.2716,962.4013,117.9611,452.24
Diluted Shares Outstanding155,105.83155,105.83137,404.1575,673.0854,673.5738,316.2716,962.4013,117.9611,452.24
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.36$-0.43
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.36$-0.43
Shares Outstanding155,105.83149,123.70148,320.80148,108.81147,812.16139,933.02130,132.96122,673.2078,217.9575,342.50
Diluted Shares Outstanding155,105.83149,123.70148,320.80148,108.81147,812.16139,933.02130,132.96122,673.2078,217.9575,342.50
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents157,304.0049,498.00225,110.00140,020.0074,843.00268,565.0043,931.0044,175.00
Short Term Investments211,395.00262,519.0034,606.00102,637.00167,872.0082,641.000.000.00
Total Cash & ST Investments368,699.00312,017.00259,716.00242,657.00242,715.00351,206.0043,931.0044,175.00
Accounts Receivable0.000.000.000.000.003.0079.00225.00
Inventory0.000.000.000.000.00-3.000.000.00
Other Current Assets5,270.004,444.004,144.005,441.004,978.002,805.000.001,306.00
Total Current Assets373,969.00316,461.00263,860.00248,098.00247,693.00354,011.0045,406.0045,706.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents139,419.00132,288.0097,122.0049,498.0079,540.00157,304.00151,941.00225,110.00133,159.00113,614.00
Short Term Investments49,302.0094,729.00166,574.00262,519.00260,576.00211,395.00113,007.0034,606.0032,112.0079,324.00
Total Cash & ST Investments188,721.00227,017.00263,696.00312,017.00340,116.00368,699.00264,948.00259,716.00165,271.00192,938.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets4,101.003,603.004,466.004,444.004,176.005,270.005,792.004,144.003,898.004,623.00
Total Current Assets192,822.00230,620.00268,162.00316,461.00344,292.00373,969.00270,740.00263,860.00169,169.00197,561.00
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment31,084.0029,343.0032,782.0035,966.0038,181.001,935.002,138.002,345.00
Goodwill0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.00
Long-Term Investments1,032.000.000.000.000.000.000.000.00
Other Long-Term Assets0.004,267.001,032.001,032.001,166.000.002,354.0098.00
Total Long-Term Assets32,116.0033,610.0033,814.0036,998.0039,347.001,935.004,492.002,443.00
Total Assets406,085.00350,071.00297,674.00285,096.00287,040.00355,946.0049,898.0048,149.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment26,739.0027,624.0028,536.0029,343.0030,219.0031,084.0031,936.0032,782.0033,615.0034,420.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.001,032.001,032.001,032.001,032.00
Other Long-Term Assets9,581.006,329.006,329.004,267.004,265.001,032.00361.000.000.000.00
Total Long-Term Assets36,320.0033,953.0034,865.0033,610.0034,484.0032,116.0033,329.0033,814.0034,647.0035,452.00
Total Assets229,142.00264,573.00303,027.00350,071.00378,776.00406,085.00304,069.00297,674.00203,816.00233,013.00
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable4,126.0010,426.005,487.007,416.0011,153.003,734.002,371.001,271.00
Short-Term Debt2,345.002,518.004,330.001,316.001,202.000.000.000.00
Other Current Liabilities10,677.0017,568.008,111.0013,628.00139.006,888.002,560.002,055.00
Current Liabilities17,148.0030,512.0017,928.0022,360.0021,744.0010,622.004,931.003,326.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable18,219.0011,515.0010,437.0010,426.006,748.004,126.003,972.005,487.004,809.007,161.00
Short-Term Debt2,818.002,716.002,616.002,518.002,437.002,345.002,254.004,330.003,402.003,232.00
Other Current Liabilities22,543.0026,411.0020,494.0017,568.0010,861.0010,677.006,907.008,111.008,959.007,498.00
Current Liabilities43,580.0040,642.0033,547.0030,512.0020,046.0017,148.0013,133.0017,928.0017,170.0017,891.00
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt27,858.0026,454.0029,190.0031,542.0033,387.000.000.000.00
Capital Leases27,858.0028,972.0031,355.0032,858.0034,589.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.00
Total Liabilities45,006.0056,966.0047,118.0053,902.0055,131.0011,668.006,368.0010,269.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt24,120.0024,914.0025,692.0026,454.0027,170.0027,858.0028,531.0029,190.0029,807.0030,398.00
Capital Leases26,938.0027,630.0028,308.0028,972.0029,607.0030,203.0028,531.0029,190.0031,508.0032,014.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities67,700.0065,556.0059,239.0056,966.0047,216.0045,006.0041,664.0047,118.0046,977.0048,289.00
Total Common Equity TTM 2024202320222021202020192018
Common Stock106.00109.0078.0048.0039.0038.004.004.00
Retained Earnings-627,285.00-710,699.00-572,499.00-438,262.00-296,315.00-165,992.00-102,580.00-65,397.00
Comprehensive Income-89.0010.00-52.00-372.00-180.00-77.00-80.00-66.00
Total Common Equity361,079.00293,105.00250,556.00231,194.00231,909.00344,278.0043,530.0037,880.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock115.00110.00109.00109.00106.00106.0090.0078.0053.0053.00
Retained Earnings-869,133.00-814,211.00-765,055.00-710,699.00-662,109.00-627,285.00-597,675.00-572,499.00-544,608.00-512,126.00
Comprehensive Income-76.00-93.00-91.0010.0077.00-89.00-102.00-52.00-123.00-171.00
Total Common Equity161,442.00199,017.00243,788.00293,105.00331,560.00361,079.00262,405.00250,556.00156,839.00184,724.00
Other TTM 2024202320222021202020192018
Total Debt30,203.0028,972.0031,355.0032,858.0034,589.000.000.000.00
Book Value361,079.00293,105.00250,556.00231,194.00231,909.00344,278.0043,530.0037,880.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value161,442.00199,017.00243,788.00293,105.00331,560.00361,079.00262,405.00250,556.00156,839.00184,724.00
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-115,159.00-206,690.00-138,200.00-134,237.00-141,947.00-130,323.00-63,412.00-37,183.00-18,304.00
Depreciation & Amortization3,074.002,166.002,150.002,148.002,106.002,141.00667.00493.00488.00
Stock-Based Compensation18,518.0016,423.0019,433.0018,183.0018,516.0016,262.004,888.002,037.00408.00
Change Working Capital-4,675.000.006,361.00-5,805.003,738.003,284.004,717.00625.00478.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.00
Change In Accounts Payable-3,382.004,491.004,936.00-2,077.00-287.003,859.001,513.00931.00-253.00
Change In Inventories0.000.000.000.000.000.000.000.000.00
Other Non-cash Items17,165.001,745.00-7,750.00-1,431.001,278.001,273.0053.005,670.00-260.00
Cash from Operations-101,744.000.000.00-121,142.00-116,309.00-106,110.00-53,087.00-28,358.00-17,190.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-48,256.00-54,922.00-49,156.00-54,356.00-48,590.00-34,824.00-29,610.00-25,176.00-27,891.00-32,482.00
Depreciation & Amortization543.00546.00540.00537.00537.00538.000.00538.00834.00538.00
Stock-Based Compensation3,305.003,835.004,205.005,078.005,222.004,609.004,942.004,660.004,367.004,549.00
Change Working Capital7,401.00-1,675.007,224.00177.009,493.00430.003,898.00-7,460.00-527.00-586.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable-3,265.006,665.001,122.00-31.003,689.002,704.0074.00-1,531.00426.00-2,351.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-8,919.00-88.00-884.00-1,491.00-2,677.00-2,768.00-939.00-829.005,349.00285.00
Cash from Operations0.000.000.000.000.000.000.000.00-23,477.00-28,291.00
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-26.00-137.00-15.00-193.00-6,526.00-1,654.00-464.00-267.00-17.00
Acquisitions-45.680.000.000.000.000.000.000.000.00
Investments-304,396.00-212,211.00-583,932.00-108,088.00-113,197.00-225,601.00-82,700.000.000.00
Sales of Investment176,194.00402,400.00365,150.00178,984.00178,166.00139,019.000.000.000.00
Other Investing Activities-77,256.320.000.000.000.000.000.000.000.00
Cash from Investing-128,228.000.000.0070,703.0058,443.00-88,236.00-83,164.00-267.00-17.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00-48.00-15.00-74.00-6.00-9.000.000.00-7.00-19.00
Acquisitions0.000.000.000.000.000.000.000.002.18-47.86
Investments-65,021.00-26,681.00-58,703.00-61,806.00-172,032.00-145,717.00-165,881.00-100,302.00-24,476.00-13,737.00
Sales of Investment38,500.0072,600.00131,800.00159,500.00173,050.0099,800.0069,300.0023,000.0022,300.0061,594.00
Other Investing Activities0.000.000.000.000.000.000.000.00-2.1847.86
Cash from Investing0.000.000.000.000.000.000.000.00-2,183.0047,838.00
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid0.000.000.000.000.000.00-500.000.000.00
Debt Issued-1,811.0028,972.00-2,383.00-1,503.00-1,731.0034,589.00500.000.000.00
Issuance of Common Stock273,212.000.000.00135,510.00130,476.000.00267,021.000.000.00
Repurchase of Common Stock0.000.000.000.000.000.00-5,193.000.000.00
Dividends Paid0.000.000.000.000.000.00-102,522.000.000.00
Other Financing Activities116,272.000.000.0014.00-7,568.001,795.00202,070.0028,395.0058,456.00
Cash from Financing273,662.000.000.00135,524.00122,908.001,795.00360,876.0028,395.0058,456.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued26,938.00-692.00-678.00-664.00-635.00-596.00-582.00-570.00-153.00-506.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00117,965.00-450.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-367.00450.00
Cash from Financing0.000.000.000.000.000.000.000.00117,598.000.00
Cash position TTM 20252024202320222021202020192018
Net Change in Cash43,690.00112,551.00-175,612.0085,090.0065,043.00-192,556.00224,634.00-244.0041,209.00
Closing Cash Balance157,304.00163,081.0050,530.00226,142.00141,052.0076,009.00268,565.0043,931.0044,175.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash22,632.007,131.0035,166.0047,624.00-30,042.00-77,764.005,363.00-73,169.0091,951.0019,545.00
Closing Cash Balance163,081.00140,451.00133,320.0098,154.0050,530.0080,572.00157,304.00152,973.00225,110.00134,191.00
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-101,770.00-186,493.00-118,021.00-121,335.00-122,835.00-107,764.00-53,551.00-28,625.00-17,207.00
Real Free Cash Flow-120,288.00-202,916.00-137,454.00-139,518.00-141,351.00-124,026.00-58,439.00-30,662.00-17,615.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-45,926.00-52,352.00-38,086.00-50,129.00-36,021.00-32,024.00-21,709.00-28,267.00-23,484.00-28,310.00
Real Free Cash Flow-49,231.00-56,187.00-42,291.00-55,207.00-41,243.00-36,633.00-26,651.00-32,927.00-27,851.00-32,859.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-3.8-5.6-1.4
P/S030.49.4
P/B4.92.25.2
P/FCF-3.9-5.8-1.5
Market cap$0.3$3.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets11.8 %7.3 %0 %
Debt to Income-12.9 %-15.2 %0 %
Debt to Free cash flow-13.3 %-295.2 %0 %
Interest expense percentage0 %-0.4 %44.7 %
Current ratio4.4 14 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-129.2 %-53.5 %0 %
ROA-91 %-43.4 %0 %
CapEx to Revenue0 %0.3 %0 %
RaD to Revenue0 %513.5 %0 %
ROEM0.0 4507.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %4.4 %68.7 %
Operating margin0 %-648.7 %35.5 %
Net margin0 %-594.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding149.1 mil 64.5 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader